Literature DB >> 24370540

Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease.

Douglas Mapel1.   

Abstract

PURPOSE OF REVIEW: This review examines the associations between chronic obstructive pulmonary disease (COPD) and renal and hepatobiliary diseases, with emphasis on the epidemiology and clinical outcomes, along with current information on pathophysiologic mechanisms and risk factors. RECENT
FINDINGS: Glomerular filtration, sodium retention, and waste excretion are abnormal in COPD and sensitive to hypoxemia and hypercarbia, but variably responsive to oxygen administration and angiotensin-converting enzyme inhibition. Newer concepts about the role of hypoxia on the progression of chronic renal failure, and improved understanding about the relationships between COPD, decreased arterial compliance, and renal glomerular injury, are bringing new insights about potential causal mechanisms between COPD and kidney diseases. Other than the well known relationship between cor pulmonale and passive liver congestion, little was known about the relationships between COPD and liver diseases until recent population-based surveys demonstrated that COPD patients have substantially elevated risk for specific hepatobiliary system diseases.
SUMMARY: Renal complications of COPD are common especially among patients with hypoxemia and hypercarbia. Renal-endocrine mechanisms, tissue hypoxia, and vascular rigidity have roles in the pathophysiology, but understanding of causal relationships is not precise. COPD patients have increased risk for hepatobiliary diseases and asymptomatic elevations of hepatic transaminases, which fortunately have relatively low prevalence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24370540     DOI: 10.1097/MCP.0000000000000024

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  9 in total

1.  Lung function and impaired kidney function in relation to metabolic syndrome.

Authors:  Kayoung Lee
Journal:  Int Urol Nephrol       Date:  2017-03-15       Impact factor: 2.370

Review 2.  Is There an Association Between Chronic Obstructive Pulmonary Disease and Chronic Renal Failure?

Authors:  Nikolaos Madouros; Sommer Jarvis; Amber Saleem; Evgenia Koumadoraki; Shayka Sharif; Safeera Khan
Journal:  Cureus       Date:  2022-06-21

3.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

4.  Economic Burden of COPD in the Presence of Comorbidities.

Authors:  David M Mannino; Keiko Higuchi; Tzy-Chyi Yu; Huanxue Zhou; Yangyang Li; Haijun Tian; Kangho Suh
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

Review 5.  Underrecognized comorbidities of chronic obstructive pulmonary disease.

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

6.  Chronic Obstructive Pulmonary Disease is associated with risk of Chronic Kidney Disease: A Nationwide Case-Cohort Study.

Authors:  Chung-Yu Chen; Kuang-Ming Liao
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

7.  Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry.

Authors:  Christiano Argano; Nicola Scichilone; Giuseppe Natoli; Alessandro Nobili; Gino Roberto Corazza; Pier Mannuccio Mannucci; Francesco Perticone; Salvatore Corrao
Journal:  Intern Emerg Med       Date:  2020-07-27       Impact factor: 3.397

8.  High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study.

Authors:  Libin Xu; Yuanhan Chen; Zhen Xie; Qiang He; Shixin Chen; Wenji Wang; Guohui Liu; Yuanjiang Liao; Chen Lu; Li Hao; Jin Sun; Wei Shi; Xinling Liang
Journal:  BMC Pulm Med       Date:  2019-09-18       Impact factor: 3.317

9.  Existence of multiple organ aging in animal model of emphysema induced by cigarette smoke extract.

Authors:  Guibin Liang; Zhihui He; Yan Chen; Hongbo Zhang; Huaihuai Peng; Dandan Zong; Yingjiao Long
Journal:  Tob Induc Dis       Date:  2022-01-17       Impact factor: 2.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.